Over-the-counter drug · OTC MONOGRAPH DRUG
Meclizine HCl (meclizine hydrochloride chewable) NDC 71335-9751
Meclizine hydrochloride 25 mg/1 · Tablet, Chewable · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-9751-0 | 71335975100 | 120 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-0)Marketed from Dec 12, 2024 | |
| 71335-9751-1 | 71335975101 | 30 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-1)Marketed from Sep 5, 2023 | |
| 71335-9751-2 | 71335975102 | 20 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-2)Marketed from Aug 10, 2023 | |
| 71335-9751-3 | 71335975103 | 25 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-3)Marketed from Dec 12, 2024 | |
| 71335-9751-4 | 71335975104 | 40 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-4)Marketed from Dec 12, 2024 | |
| 71335-9751-5 | 71335975105 | 60 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-5)Marketed from Dec 12, 2024 | |
| 71335-9751-6 | 71335975106 | 90 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-6)Marketed from Jun 19, 2024 | |
| 71335-9751-7 | 71335975107 | 8 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-7)Marketed from Dec 12, 2024 | |
| 71335-9751-8 | 71335975108 | 14 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-8)Marketed from Aug 21, 2024 | |
| 71335-9751-9 | 71335975109 | 10 TABLET, CHEWABLE in 1 BOTTLE (71335-9751-9)Marketed from Aug 7, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Meclizine HCl
- Generic name (nonproprietary)
- meclizine hydrochloride chewable
- Active ingredients
- Meclizine hydrochloride — 25 mg/1
- Dosage form
- Tablet, Chewable
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Over-the-counter drug
- Marketing category
- OTC monograph drugApplication M009.50
- Marketing start
- Listing expires
- Other FDA classes
- Emesis Suppression (Physiologic effect)
- Identifiers
- Product ID 71335-9751_b5813836-d2ea-4aea-b894-fe428dd7e91dSPL ID b5813836-d2ea-4aea-b894-fe428dd7e91dSPL set ID 12446adb-0ff6-4f92-8bb2-b64b11d47e76RxCUI 995632UNII HDP7W44CIO
- Pharmacologic class
- Antiemetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335975100followed by a unit qualifier and the quantityPackage 71335-9751-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses prevents and treats nausea, vomiting or dizziness due to motion sickness.
Excerpt only. Read the full label for complete information.
Other NDCs under M009.50
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meclizine HClmeclizine hydrochloride | Meclizine hydrochloride 12.5 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 57237-333 |
| Meclizine HClmeclizine hydrochloride chewable | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | Rising Pharma Holdings, Inc. | 16571-824 |
| Diphenhydramine Oral Liquiddiphenhydramine hydrochloride | Diphenhydramine hydrochloride 12.5 mg/5mL | LiquidOral | Rising Pharma Holdings, Inc. | 57237-305 |
| Diphenhydramine HCl Oral Solutiondiphenhydramine hcl oral | Diphenhydramine hydrochloride 12.5 mg/5mL | SolutionOral | Rising Pharma Holdings, Inc. | 57237-317 |
| Diphenhydramine HCl Oral Solutiondiphenhydramine hcl oral | Diphenhydramine hydrochloride 25 mg/10mL | SolutionOral | Rising Pharma Holdings, Inc. | 57237-318 |